The importance of quality assurance is emphasized internationally in 'Cancer Incidence in Five Continents' (Parkin and Muir, 1992) and, in the UK, by its inclusion in regional corporate contracts for cancer registration (NHS Management Executive, 1996) .
Four attributes of registry data quality are described. Ascertainment is 'the degree to which reportable incident cases ... are actually recorded in the registry' (Robles et al, 1988) . It is variously termed 'accuracy', 'completeness', 'completeness of registration' and 'completeness of ascertainment' by authors. The use of 'ascertainment' alone avoids confusion with completeness of detail and is consistent with the English meaning (Collins Concise English Dictionary, 1982) . Completeness (of detail) describes the extent to which all appropriate data items have been recorded . Timeliness describes the currency of registry data. Validity is 'the proportion of cases recorded with a given characteristic (sex, age, diagnosis) which truly has this attribute' (Parkin and Muir, 1992) .
MCCR ascertainment has previously been reported as 88.7% for childhood cancers compared with 91.8% in England and Wales (Hawkins and Swerdlow, 1992) . Incidence to mortality ratios for lung cancer were 1.12 and 1.11 for men and women, respectively, in 1989, compared with equivalent ratios for England and Wales of 1.06 and 1.07 (OPCS, 1994) . These measures, although limited, imply ascertainment worse than the national average in MCCR. Similarly, MCCR ranks seventh out of nine UK registries submitting 667 data internationally for the overall proportion histologically verified: 66% men and 71% women compared with equivalent figures from the Oxford Regional Registry of 76% and 80% (Parkin and Muir, 1992) , implying suboptimal validity. The dearth of information about the quality of MCCR data, and the implication from the small amount published that improvement is needed, prompted the aims of this study, i.e. to identify data quality measures from the literature, apply them to MCCR data and make recommendations for quality assurance extendable to other registries.
MATERIALS AND METHODS
Published papers, reference volumes, OPCS publications and reports from UK and overseas registries were searched to identify measures of cancer registry data quality. Measures of ascertainment, completeness, timeliness and validity were selected according to their reproducibility (adequately described with few assumptions, clear definitions and simple calculations), practicability (relevant information collected by MCCR) and potential comparability with data from other registries.
Data items, e.g. age at diagnosis, cancer site coded to three digits in ICD-O [International Classification of Diseases for Oncology (Version 1)] and district of residence at diagnosis, were selected according to their association with previously identified measures on all registered cases diagnosed in 1990 and 1991 to form the study database. The measures were then applied to the study database and analysed by district of residence, age at diagnosis and cancer site.
For measures requiring information about notification source, which was not computerized in MCCR, the paper records of cases registered after death were audited separately to determine those cases that were uniquely dependent on the DC for notification and the accuracy of death certificate only (DCO) cases identification. For cases registered from a DC, by local convention, date of death is also entered on to the computer as date of diagnosis until more information becomes available, thereby flagging DCO cases. Four random samples of registrations after death were selected, according to the presence or absence of the DCO flag and the length of the death to registration interval. Sample sizes were calculated for a population survey with a single parameter having an estimated frequency of 50%. Sample paper records were searched manually for independent source documents, forming an audit database of key identifying variables and information about notification source. Representativeness was confirmed by comparing the frequencies of five variables (sex, age group, site, year of diagnosis and district of residence) between each sample and the study database. Death certificate-dependent (DCD) registrations were defined as those containing a death certificate as the only notifying paper document. Records containing notifications from other sources (e.g. pathology), even if first notified by DC, were regarded as independently notified. DCDs were reclassified as DC-plus registrations when registry enquiry (traceback) yielded additional information, and DCO registrations when traceback was unsuccessful.
When possible, results are presented with confidence limits, calculated using standard formulae (Gardner and Altman, 1992) . Statistical significance was assessed using the Kruskal-Wallis test for analysis of variance and Spearman's rank correlation coefficient.
RESULTS
Ten measures were identified from the literature (Table 1) , all lacking explicit standards. The study database contained 27 942 primary cancers diagnosed in 1990 and 1991, of which 8535 Freedman (1978) Cases uniquely notified by Goldberg et al (1980) death certificate Skeet (1991) Death certificate -notified proportion (DCN%) Benn et al (1982) Cases first notified by Parkin et al (1994) death (Table 3) , although variable, exceeded unity; ratios for stomach cancer were appropriately and consistently higher than those for lung, reflecting better survival. Table 4 shows considerable variation between sites for capture-recapture estimates. The 'all sources' estimate of ascertainment (59.4% overall) was greater than the 'two source' estimate (52.5% overall), because cases ascertained from other sources (e.g. hospital information systems) were included. Ascertainment appeared low for sites like female breast in which overlap between sources was small, i.e. when survival is longer and hence there are fewer DC notifications. When overlap was greater, e.g. for lung, ascertainment appeared to be higher. For sites with effectively a single source (e.g. testis -pathology only), the method failed as there was no 'recapture'.
From the audit, the DCD% (cases uniquely notified by DC) was 65.6% (5601 out of 8535) of registrations after death and 20% (5601 out of 27 942) overall, comprising 24.2% (2068) DCO cases and 41.4% (3533) DC-plus cases ( Table 2 ). The DC-notified proportion (DCN%) (casesfirst notified by DC) was an estimated 96.7% (8255 out of 8535) of cases registered after death and 29.5% (8255 out of 27 942) overall, comprising 5601 DCD cases, 293 DC-independent cases (DCO flagged and thus triggered by a DC) and 2361 unflagged cases registered within 6 weeks of death (likely to have been triggered by a DC). An estimated 2934 (34.4%) registrations after death were DC independent.
Completeness
The proportion of cases with an unknown primary site varied significantly among districts (Table 5 ) and with age, being low initially in children and young adults but increasing thereafter (Table 6 ). Date of birth and sex were missing in 13 and two records (< 0.01%) respectively.
Timeliness
The median diagnosis to registration interval for Mersey region was 10 weeks. An exceptional interval of 24 weeks in district 7 compared with a range from 8 to 12 weeks in other districts (Kruskall-Wallis P < 0.0001) ( Table 5 ). The interval decreased with increasing age (Spearman rank P < 0.0001) ( Table 6 ) and varied significantly with site from 8 weeks (oesophagus) to 16 weeks (brain) ( increasing to a plateau between ages 25 and 34 years and thereafter decreasing (Table 6 ). (Robles et al, 1988) . However, Robles' study was reported 6 years after the incident year (compared with 8 months in our study), leading to more observed cases and more overlap between sources (e.g. death certificate and pathology), particularly affecting sites with longer survival such as breast and cervical cancer. Also, the accurate identification of source in Robles' study allowed three sources to be used (compared with two in our study), thereby strengthening the method. The method is most robust when capture and recapture give similarly sized groups, are clearly independent and have considerable overlap. Capture-recapture fails when there is a single source (e.g. for testicular cancer, which has excellent survival) and overestimates ascertainment when sources are mutually dependent (e.g. between death certificate and post-mortem data). Capture-recapture results here may thus illustrate the method's shortcomings as much as they measure local ascertainment. However, the method deserves further testing (perhaps against independent clinical case registers) and could be refined for cancer registry use by specifying the time interval after the incident year, using multiple sources, considering sites individually and adjusting for survival time.
Both R/M ratios and capture-recapture depend on multiple sources of information and, although probably less accurate, are easier to apply routinely than more resource intensive comparisons with clinical case registers (which tend to be site specific and have limited population coverage) or data reabstraction methods.
The DCD% estimated from audited registrations after death was preferred to the more familiar DCN%, which refers to cases first notified by DC. The DCD%, in identifying uniquely DC notified cases, is the better measure of ascertainment as 'accidents of timing', occurring when DC information apparently arrives in the Registry first, are eliminated. In MCCR, death certificates are processed before information from other sources to maximize the likelihood of successful traceback. Thus, rapidly fatal cancers in particular may be notified first, but not uniquely, by DC, and data processing backlogs, common to many registries, make ascertainment measured by DCN% appear worse by affecting timeliness.
Overall DCD% and DCN% were estimated as 20.0% and 29.5%, respectively, illustrating the potential for distortion. Routine description of the DCD% is impossible, however, without information about notification source. There are no comparable data from other registries.
Approximately 10% of records selected for audit were 'not in file' mainly through removal for research and (paradoxically) verification purposes. Filing has since been reorganized!
Completeness
The overall proportion with primary site unknown (1.5%) appears to have improved compared with levels of 6.23% and 6.95% for men and women respectively (Parkin and Muir, 1992) , although the best district value of 0.8% indicates that further local improvement is possible. Improvement may reflect extensions in the range and application of diagnostic techniques. Although there are no comparable published reports about other missing key information, the overall proportions in MCCR appear acceptably low.
The DCO% measures completeness, as key data items such as date of diagnosis are missing, and validity (see on) mainly by affecting diagnostic accuracy. The effect of these deficiencies on incidence and survival analyses clearly depends upon the magnitude of the DCO% and the degree to which DCO cases are atypical. DCO registrations represent ascertainment failures comprising genuine diagnoses after death and cases unreported in life for which traceback has either been unsuccessful or has not been attempted. In MCCR, DCO registrations (7.4%) were overestimated by the DCO flag (8.9%). Misclassification arose through clerical failure to reset date of diagnosis (from date of death) when additional information was found, with clear implications for training. DC-independent cases, incorrectly DCO flagged, arose through data processing backlogs during recomputerization, which differentially affected sources other than death certificates. Similar mechanisms probably account for the variation in the positive predictive value of the DCO flag with death to registration interval. In MCCR, variations in the DCO-flagged proportion by site, age and district are likely to be a reasonable reflection of true DCO% variation (positive predictive value 83%) and raise issues for exploration with data providers. Traceback was successful in 3533 out of 5601 (63.1%) DCD cases, thereby improving validity and completeness, as otherwise all DCD registrations would eventually be classified DCO. The DC-plus% estimated here provides a new marker of ante-mortem reporting failure. Less biased than DCO registrations, most DCplus cases are randomly 'missed pathology', causing delays rather than failures in record completion, and may be indistinguishable in content from registrations completed chronologically. There are no comparable figures from other registries.
Timeliness
MCCR registration timeliness compares favourably with elsewhere, with median diagnosis to registration intervals of 10 weeks and 24 weeks for MCCR and South Thames respectively (Thames Cancer Registry, 1995) . In MCCR, statistically significant variations in the diagnosis to registration interval are highlighted by site, district and age group. Explanations for delays include complex childhood cancer records not being available to registration clerks, routine failure to notify histological diagnoses, especially in district 7, and a greater proportion of 'faster' DC notifications among older people and in some districts. The implications of these findings need to be explored with individual providers if registration is to be improved. Commonly registered more promptly that registrations via pathology, DCO cases should ideally be excluded from calculations of timeliness, but they were known only for the audited records, precluding their exclusion here. Comparisons with other registries were limited by the lack of published data, although South Thames data also showed some variation with site and district (Thames Cancer Registry, 1995) .
The diagnosis to registration interval (expressed as median and 75th percentile) uses routinely available data from the Cancer Minimum Data Set (NHS Management Executive, 1992) and depends upon ascertainment and the elapsed time from the incident year. This time could be standardized to allow more meaningful comparison between registries, thereby better reflecting the process of registration.
Validity
Variations in the proportion of histologically verified diagnoses by site (Centre for Cancer Epidemiology, 1992; Parkin and Muir, 1992) and age (Parkin and Muir, 1992) The DCO% as a validity measure is complementary to verification of diagnosis (Parkin and Muir, 1992) . Previously reported inconsistencies in the DCO complicate the interpretation of international comparisons of incidence (Parkin et al, 1994) and survival (Berrino et al, 1995) . Differences between UK regions probably also result from variable traceback procedures. The significant district variation found in MCCR is, however, likely to be attributable to differences in other factors, such as demography, incidence, clinical management and survival between population subgroups and clearly needs further work.
Intemational DCO% are published in 'Cancer Incidence in Five Continents' (Parkin and Muir, 1992), although they were omitted for MCCR recently (1983-87 data) precluding accurate comparison. DCO% appear in some, but not all, registry reports and are generally lower than in MCCR but show similar variation by site (Black et al, 1993; Thames Cancer Registry, 1995) , district (Centre for Cancer Epidemiology, 1992) and age (Parkin and Muir, 1992) . The shorter time interval (8 months) for successful traceback between the end of the study period and the creation of the study dataset partly explains the high overall DCO%, contrasting with intervals of over 3 years elsewhere (Centre for Cancer Epidemiology, 1992; Parkin and Muir, 1992; Black et al, 1993; Thames Cancer Registry, 1995) .
Inconsistencies in the DCO% should be resolved by stricter definition. Conceptually, the DCO is a registration in which 'no information other than the death certificate is available' . Availability is relative and time dependent -whether additional information can be found varies with registry effort and resources. Pragmatically, the definition 'DCO' could apply to a record containing only DC information, for example 24 months after death, making the DCO% the proportion of records in which 'only death certificate information is held at 24 months after death, despite specified search by the registry'. Improbable or impossible dates are rarely revealed in registry reports. In MCCR, 2% of records were apparently registered before their diagnosis. Local discussion suggests that this arises when dates are imputed by computer software when information is missing, and through keyboard errors.
CONCLUSION
Although the importance of high-quality cancer registration has been highlighted (Day and Davies, 1996) , the means of achievement seems less clear. Accurate cancer registry information is essential for the definition, development and monitoring of Cancer Units and Centres (Department of Health, 1994) , and quality now forms part of the national core contract (NHS Executive, 1996) for cancer registries. While attempting to put quality assurance into practice at local level, this study has demonstrated shortcomings in the scope, definition and use of existing quality assurance measures, and the absence of explicit standards. Suggestions are made about clarifying terminology, standardizing existing definitions and adding new measures. Without this, national and international data comparisons are impoverished, variations can be ignored as artefactual and data do not improve, ultimately casting doubt on their use. The measures used here could, with further development, form the basis of national quality assurance, alongside the much needed standardization of registry procedutes. Custom and practice must now give way to a systematic and standardized approach to quality assurance in cancer registries.
